Related Experiment Videos
Paracetamol metabolism in pregnancy
British Journal of Clinical Pharmacology
|September 1, 1986
Summary
Pregnant women metabolize paracetamol (acetaminophen) faster due to increased glucuronidation and oxidative pathways. This leads to higher apparent oral clearance and a shorter elimination half-life compared to non-pregnant women.
Area of Science:
- Pharmacokinetics
- Drug Metabolism
- Pregnancy Research
Background:
- Paracetamol (acetaminophen) is a widely used analgesic and antipyretic.
- Understanding drug disposition during pregnancy is crucial for maternal and fetal safety.
- Previous studies suggest altered drug metabolism in pregnant individuals.
Purpose of the Study:
- To investigate and compare the disposition of paracetamol in pregnant versus non-pregnant women.
- To elucidate the metabolic pathways responsible for any observed differences in paracetamol pharmacokinetics.
Main Methods:
- Comparative pharmacokinetic study involving pregnant and age-matched non-pregnant women.
- Analysis of paracetamol apparent oral clearance and elimination half-life.
- Assessment of glucuronidation, oxidative, sulphation, and renal clearance pathways.
Main Results:
- Paracetamol apparent oral clearance was 58% higher in pregnant women.
- Elimination half-life of paracetamol was 28% lower in pregnant women.
- Increased activity in glucuronidation (75%) and oxidative (88%) metabolic pathways observed in pregnant women.
Conclusions:
- Pregnancy significantly alters paracetamol disposition, primarily through enhanced glucuronidation and oxidative metabolism.
- These metabolic changes result in faster paracetamol clearance and a shorter duration of action during pregnancy.
- No significant differences were found in paracetamol sulphation or renal clearance between the groups.